Kromek

Capital Markets Day | 18th June 2025

Kromek CMD 2025 Presentation

Capital Markets Days

Subscribe to receive announcements and updates from Kromek.

Webinars

Updates

Announcements

News and Media

Our Management Team

The Board

Corporate Governance

Who we are

Home

Investor Questions

Key Contacts

Company Documents

Number of Securities in Issue

Significant Shareholders

Directors' Interests

AIM Rule 26

DM Sans

Kromek Investor Hub

As a global leader in advanced imaging and CBRN (Chemical, Biological, Radiological, and Nuclear) detection technology, Kromek is committed to delivering best-in-class solutions that drive safer, healthier communities worldwide. With a proven track record of innovation and robust year-on-year growth, Kromek is targeting medium-term revenues exceeding £60 million and a 30% EBITDA margin, building on the momentum from our expanding partnerships and strong divisional performance in Advanced Imaging and CBRN Detection.

Hear from our CEO, Arnab Basu, our CFO, Claire Burgess, as well as the senior management team, about our business foundations, leadership vision, and the strategic value we deliver across the Group. 

Learn more about our two businesses Advanced Imaging and CBRN Detection and hear why they are two growth pillars for us.

See more presentation and testimonial videos from our 2025 Capital Markets Day

Gallery